These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 10729966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy.
    Sane DC, Damaraju LV, Topol EJ, Cabot CF, Mascelli MA, Harrington RA, Simoons ML, Califf RM.
    J Am Coll Cardiol; 2000 Jul; 36(1):75-83. PubMed ID: 10898416
    [Abstract] [Full Text] [Related]

  • 3. Thrombocytopenia associated with c7E3 Fab (abciximab).
    Schell DA, Ganti AK, Levitt R, Potti A.
    Ann Hematol; 2002 Feb; 81(2):76-9. PubMed ID: 11907786
    [Abstract] [Full Text] [Related]

  • 4. Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab.
    Stiegler H, Fischer Y, Steiner S, Strauer BE, Reinauer H.
    Ann Hematol; 2000 Mar; 79(3):161-4. PubMed ID: 10803940
    [Abstract] [Full Text] [Related]

  • 5. The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.
    Davidson SJ, Turner N, Clague JR, Oldershaw PJ, Burman JF.
    Thromb Haemost; 1999 Nov; 82(5):1560-1. PubMed ID: 10595660
    [No Abstract] [Full Text] [Related]

  • 6. Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia.
    Dorsch MP, Montague D, Rodgers JE, Patterson C.
    Pharmacotherapy; 2006 Mar; 26(3):423-7. PubMed ID: 16503724
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention.
    Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard MR, Frelinger AL, Michelson AD.
    Am Heart J; 2003 Feb; 145(2):e6. PubMed ID: 12595861
    [Abstract] [Full Text] [Related]

  • 9. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
    Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D.
    Circulation; 2004 May 11; 109(18):2203-6. PubMed ID: 15117843
    [Abstract] [Full Text] [Related]

  • 10. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M, Ruf A, Neumann FJ, Pogátsa-Murray G, Dickfeld T, Zohlnhöfer D, Schömig A.
    Thromb Haemost; 1998 Dec 11; 80(6):994-1001. PubMed ID: 9869173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
    Nguyen N, Salib H, Mascarenhas DA.
    J Invasive Cardiol; 2001 Jan 11; 13(1):56-8. PubMed ID: 11146690
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amikacin can be added to blood to reduce the fall in platelet count.
    Zhou X, Wu X, Deng W, Li J, Luo W.
    Am J Clin Pathol; 2011 Oct 11; 136(4):646-52. PubMed ID: 21917689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.